Sarah E. Daadi

1.2k citations

9 papers · 854 indexed · 1 hit paper · h-index 5

Impact in

Pathology and Forensic Medicine top 2%
- Lymphoma Diagnosis and Treatment
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Viral-associated cancers and disorders

Papers in

Pathology and Forensic Medicine 9
- Lymphoma Diagnosis and Treatment 9
Oncology 6
- Viral-associated cancers and disorders 5
- Cancer Immunotherapy and Biomarkers 1

Co-authors: Richard T. Hoppe Ranjana H. Advani Yasodha Natkunam Azra H. Ligon Daphne de Jong Donna Neuberg Scott J. Rodig Bjoern Chapuy
Journals: Journal of Clinical Oncology (3 papers)Blood (2 papers)JCO Oncology Practice (1 paper)Cancer Immunology Research (1 paper)Annals of Oncology (1 paper)
Partner nations: United States Netherlands

In The Last Decade

Sarah E. Daadi

9 papers receiving 849 citations

Hit Papers

align trajectories log scale

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome 2016 · 555 citations

Peers

Countries citing papers authored by Sarah E. Daadi

Since Specialization

Citations

This map shows the geographic impact of Sarah E. Daadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Daadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Daadi more than expected).

Fields of papers citing papers by Sarah E. Daadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Daadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Daadi. The network helps show where Sarah E. Daadi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sarah E. Daadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah E. Daadi Line = papers co-authored together Sarah E. Daadi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work
1	Long-term outcomes of patients with unfavorable stage I–II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation Leukemia & lymphoma ·Sue Kim, Yushen Qian, Rie von Eyben, Sarah E. Daadi, 玲香坂, Saul A. Rosenberg, Ranjana H. Advani, Richard T. Hoppe	2020	2
2	Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study JCO Oncology Practice ·Ryan C. Lynch, Vandana Sundaram, Manisha Desai, Solomon Henry, Douglas Wood, Sarah E. Daadi, Richard T. Hoppe, Ranjana H. Advani	2020	2
3	Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status Cancer Immunology Research ·Margaretha G.M. Roemer, Ranjana H. Advani, Robert Redd, Geraldine S. Pinkus, Yasodha Natkunam, Azra H. Ligon, Courtney Connelly, Christine J. Pak, Christopher D. Carey, Sarah E. Daadi, Bjoern Chapuy, Daphne de Jong, Richard T. Hoppe, Donna Neuberg, Margaret A. Shipp, Scott J. Rodig	2016	139
4	PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome Journal of Clinical Oncology ·Margaretha G.M. Roemer, Ranjana H. Advani, Azra H. Ligon, Yasodha Natkunam, Robert Redd, Heather Homer, Courtney Connelly, Heather H. Sun, Sarah E. Daadi, Gordon J. Freeman, Philippe Armand, Bjoern Chapuy, Daphne de Jong, Richard T. Hoppe, Donna Neuberg, Scott J. Rodig, Margaret A. Shipp Hit paper breakdown →	2016	555
5	PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome Blood ·Е. А. Котелевская, Ranjana H. Advani, Azra H. Ligon, Yasodha Natkunam, Robert Redd, Heather Homer, Courtney Connelly, Heather H. Sun, Sarah E. Daadi, Bjoern Chapuy, Daphne de Jong, Richard T. Hoppe, Donna Neuberg, Scott J. Rodig, Margaret A. Shipp	2015	59
6	Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte–Predominant Hodgkin Lymphoma Journal of Clinical Oncology ·Ranjana H. Advani, Sandra J. Horning, Richard T. Hoppe, Sarah E. Daadi, John Allen, Yasodha Natkunam, Nancy L. Bartlett	2014	74
7	Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial Annals of Oncology ·Ranjana H. Advani, Richard T. Hoppe, D. Baer, R. Demina, R Warnke, Jeffrey C. Allen, Sarah E. Daadi, Saul A. Rosenberg, SJ Horning	2012	17
8	Abbreviated 8-week chemotherapy (CT) plus involved node radiotherapy (INRT) for nonbulky stage I-II Hodgkin lymphoma: Preliminary results of the Stanford G5 Study. Journal of Clinical Oncology ·Ranjana H. Advani, SJ Horning, Hyoun-Gyu Park, Sarah E. Daadi, J.P. Allen, S A Rosenberg, Richard T. Hoppe	2011	3
9	Frontline Therapy of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Rituximab: The Stanford University Experience Blood ·Ranjana H. Advani, Sandra J. Horning, Richard T. Hoppe, Sarah E. Daadi, John Allen, Yasodha Natkunam, Alex McMillan, Nancy L. Bartlett	2011	3

About Sarah E. Daadi

Sarah E. Daadi is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Pulmonary and Respiratory Medicine and Cancer Research, having authored 9 papers that have together received 854 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (5 papers), Lung Cancer Treatments and Mutations (5 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer Genomics and Diagnostics (1 paper), Immune Cell Function and Interaction (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (594 citations), Oncology (657 citations), Immunology (346 citations), Genetics (119 citations) and Neurology (158 citations). Sarah E. Daadi has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Richard T. Hoppe, Ranjana H. Advani, Yasodha Natkunam, Azra H. Ligon, Daphne de Jong, Donna Neuberg, Scott J. Rodig, Bjoern Chapuy, Courtney Connelly and Margaret A. Shipp. Their work appears in journals such as Journal of Clinical Oncology, Blood, JCO Oncology Practice, Cancer Immunology Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact